Official NEBA Releases

Integration of an EEG biomarker with a clinician’s ADHD evaluation
NEBA Health Releases Key Study Results
NEBA Health Key Results Summary
ACAAP 2013 - poster: Evaluation of a method that integrates an EEG biomarker with a clinician's assessment of ADHD - FDA permits marketing of first brain wave test to help assess children and teens for ADHD (external link) - De Novo Classification Request For Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System (external link)
Biological Markers in Diagnosis of ADHD: EEG Theta/Beta Ratio in Diagnosis of ADHD. Pediatric Neurology Briefs. (external link)
Annotated bibliography (as of 2019.01.08) for Omega-3 research